Article info
Editorial commentary
Novel evidence associates higher plasma α-synuclein levels and cognitive impairment in Parkinson’s disease
- Correspondence to Professor Dag Aarsland, Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, 16, De Crespigny Park, London SE5 8AF, UK; dag.aarsland{at}kcl.ac.uk
Citation
Novel evidence associates higher plasma α-synuclein levels and cognitive impairment in Parkinson’s disease
Publication history
- Received May 5, 2017
- Accepted May 17, 2017
- First published June 12, 2017.
Online issue publication
September 11, 2017
Article Versions
- Previous version (12 June 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.